The abstracts of the CTAD are available in PDF format, you can download them on

this link

The abstracts of the ICFSR are available in PDF format, you can download them on this link

this link

The abstracts of the ICFSR are available in PDF format, you can download them on this link

this link

AlzheimerNews

News Plasma Biomarkers of AD Emerging as Essential Tools for Drug Development: an EU/US CTAD Task Force Report

There is an urgent need to develop reliable and sensitive bloodbased biomarkers of Alzheimer’s disease (AD) that can be used for screening and to increase the efficiency of clinical trials. The European Union-North American Clinical Trials in Alzheimer’s Disease Task… Continue Reading →

News Combination Therapy for Alzheimer’s Disease: Perspectives of the EU/ US CTAD Task Force

Combination therapy is expected to play an important role for the treatment of Alzheimer’s disease (AD). In October 2018, the European Union-North American Clinical Trials in Alzheimer’s Disease Task Force (EU/US CTAD Task Force) met to discuss scientific, regulatory, and… Continue Reading →

News Anti-Tau Trials for Alzheimer’s Disease: A report from the EU/US CTAD Task Force

Efforts to develop effective disease-modifying treatments for Alzheimer’s disease (AD) have mostly targeted the amyloid β (Aβ) protein; however, there has recently been increased interest in other targets including phosphorylated tau and other forms of tau. Aggregated tau appears to… Continue Reading →

© 2019 Aging-news — Powered by WordPress

Theme inspired by Anders NorenUp ↑